Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 7
Submit an article Journal homepage
281
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes

Genya Aharon-HananelDiabetes Medical Center, Tel Aviv, Israel;Endocrine Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, IsraelView further author information
&
Itamar RazDiabetes Medical Center, Tel Aviv, Israel;Hadassah Hebrew University Hospital, Jerusalem, IsraelCorrespondence[email protected]
View further author information
Pages 781-790 | Received 25 Nov 2018, Accepted 12 Feb 2019, Published online: 05 Mar 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shubham Batra, Prabhjeet Kaur Bamrah & Manjusha Choudhary. (2023) Sodium-glucose transporter (SGLT2) inhibition: A potential target for treatment of type-2 Diabetes Mellitus with Natural and Synthetic compounds. Egyptian Journal of Basic and Applied Sciences 10:1, pages 69-82.
Read now

Articles from other publishers (3)

Xiaojiao Li, Xiaoxue Zhu, Jingrui Liu, Qianqian Li, Hong Zhang, Cuiyun Li, Min Wu, Lei Gao, He Wen, Xixi Li, Xinran Tang, Li Liu & Yanhua Ding. (2020) Pharmacokinetics, pharmacodynamics and tolerability of single and multiple doses of janagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, in Chinese people with type 2 diabetes mellitus . Diabetes, Obesity and Metabolism 22:12, pages 2316-2324.
Crossref
Satish K. Garg, Scott Brackett, Trenton Reinicke & Irl B. Hirsch. (2020) New Medications for the Treatment of Diabetes. Diabetes Technology & Therapeutics 22:S1, pages S-149-S-173.
Crossref
Kashif Haider, Ankita Pathak, Ankit Rohilla, Md Rafi Haider, Kamal Ahmad & M. Shahar Yar. (2019) Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. European Journal of Medicinal Chemistry 184, pages 111773.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.